| Literature DB >> 28842245 |
Kuniyuki Endo1, Shinsuke Ishigaki2, Yoshito Masamizu3, Yusuke Fujioka1, Akiya Watakabe4, Tetsuo Yamamori4, Nobuhiko Hatanaka5, Atsushi Nambu5, Haruo Okado6, Masahisa Katsuno1, Hirohisa Watanabe7, Masanori Matsuzaki3, Gen Sobue8.
Abstract
Fused in sarcoma (FUS) is an RNA binding protein that is involved in frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). To establish the common marmoset (Callithrix jacchus) as a model for FTLD, we generated a stereotaxic injection-based marmoset model of FUS-silencing. We designed shRNAs against the marmoset FUS gene and generated an AAV9 virus encoding the most effective shRNA against FUS (shFUS). The AAV encoding shFUS (AAV-shFUS) was introduced into the frontal cortex of young adult marmosets, whereas AAV encoding a control shRNA was injected into the contralateral side. We obtained approximately 70-80% silencing of FUS following AAV-shFUS injection. Interestingly, FUS-silencing provoked a proliferation of astrocytes and microglias. Since FTLD is characterized by various emotional deficits, it would be helpful to establish a marmoset model of FUS-silencing in various brain tissues for investigating the pathomechanism of higher cognitive and behavioral dysfunction.Entities:
Keywords: Common marmoset; FUS; Frontotemporal lobar degeneration
Mesh:
Substances:
Year: 2017 PMID: 28842245 DOI: 10.1016/j.neures.2017.08.006
Source DB: PubMed Journal: Neurosci Res ISSN: 0168-0102 Impact factor: 3.304